# Clinical Study of New Intensive Treatment Regimen for Severe Nontuberculous Mycobacterial Pulmonary Disease

> **NCT05494957** · PHASE4 · UNKNOWN · sponsor: **Shanghai Pulmonary Hospital, Shanghai, China** · enrollment: 40 (estimated)

## Conditions studied

- Nontuberculous Mycobacterial Lung Disease

## Interventions

- **DRUG:** New regimen(BdqCfzLzd+XY)

## Key facts

- **NCT ID:** NCT05494957
- **Lead sponsor:** Shanghai Pulmonary Hospital, Shanghai, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-05
- **Primary completion:** 2024-08-05
- **Final completion:** 2025-08-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-08-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05494957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05494957, "Clinical Study of New Intensive Treatment Regimen for Severe Nontuberculous Mycobacterial Pulmonary Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05494957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*